RANKL Polyclonal antibody

RANKL Polyclonal Antibody for IHC,ELISA

Host / Isotype

Rabbit / IgG


human and More (2)





Cat no : 23408-1-AP


CD254, hRANKL2, ODF, OPGL, OPTB2, Osteoprotegerin ligand, RANKL, sOdf, TNFSF11, TRANCE

Tested Applications

Positive IHC detected inhuman osteosarcoma tissue, human colon tissue, human heart tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Immunohistochemistry (IHC)IHC : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

The immunogen of 23408-1-AP is RANKL Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen RANKL fusion protein Ag19975
Full Name tumor necrosis factor (ligand) superfamily, member 11
Calculated molecular weight 317 aa, 35 kDa
GenBank accession numberBC074890
Gene symbol TNFSF11
Gene ID (NCBI) 8600
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

TNFSF11 also known as RANKL, is a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. RANKL is a polypeptide of 217 amino acids that exerts its biological activity both in a transmembrane form of about 40-45 kDa and in soluble one of 31 kDa (PMID: 15308315). The membrane-bound RANKL (mRANKL) is cleaved into a sRANKL by the metalloprotease-disintegrin TNF-alpha convertase (TACE) or a related metalloprotease (MP). RANKL induces osteoclast formation through its receptor, RANK, which transduces signals by recruiting adaptor molecules, such as the TNF receptor-associated factor (TRAF) family of proteins. RANKL was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. RANKL was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis.


Product Specific Protocols
IHC protocol for RANKL antibody 23408-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Med Sci Monit

Fluid Shear Stress Suppresses Osteoclast Differentiation in RAW264.7 Cells through Extracellular Signal-Regulated Kinase 5 (ERK5) Signaling Pathway.

Authors - Chongwen Ma


The effects of binge alcohol exposure on tooth movement and associated root resorption in rats.

Authors - Fan Yang

Food Nutr Res

Genistein prevents bone loss in type 2 diabetic rats induced by streptozotocin.

Authors - Rongrong Lu

Biomed Res Int

Total Saponins from Nigella glandulifera Seeds Ameliorate Adjuvant-Induced Rheumatoid Arthritis in Rats by Inhibition of an Inflammatory Response and Bone Erosion.

Authors - Li Zeng

Mol Med Rep

MicroRNA‑21 serves an important role during PAOO‑facilitated orthodontic tooth movement.

Authors - Yuanyuan Zhang

Ren Fail

Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.

Authors - Qiong Xiao